Table 2—
No retinopathy | Incident retinopathy | P value | |
---|---|---|---|
n | 287 | 25 | |
Age (years) | 60 ± 11 | 63 ± 10 | 0.175 |
Male sex (%) | 53 | 60 | 0.499 |
FPG (mmol/l) | 7.6 ± 1.9 | 10.8 ± 3.8 | <0.001 |
2-h plasma glucose (mmol/l)* | 12.4 ± 3.6 | 16.2 ± 6.9 | 0.006 |
A1C (%) | 6.3 ± 1.2 | 8.5 ± 1.9 | <0.001 |
C-peptide (ng/ml) | 3.9 ± 1.7 | 2.9 ± 1.8 | 0.007 |
Known diabetes (%) | 43 | 80 | 0.001 |
Duration of diabetes (years)† | 0 (0–3) | 5 (2–9) | <0.001 |
Taking insulin or tablets (%) | 57 | 90 | 0.007 |
BMI (kg/m2) | 30.4 ± 5.9 | 29.1 ± 6.1 | 0.296 |
Waist circumference (cm) | 101.4 ± 13.7 | 98.8 ± 12.9 | 0.366 |
Albumin-to-creatinine ratio (mg/mmol) | 0.8 (0.5–1.6) | 1.2 (0.5–4.5) | 0.115 |
Lipid treatment (%) | 26 | 28 | 0.001 |
HDL cholesterol (mmol/l) | 1.2 ± 0.3 | 1.2 ± 0.4 | 0.971 |
Total cholesterol (mmol/l) | 5.7 ± 1.0 | 5.2 ± 0.9 | 0.026 |
Triglycerides (mmol/l) | 1.9 (1.3–2.8) | 1.7 (0.8–2.6) | 0.189 |
Current smoker (%) | 10 | 4 | 0.334 |
Hypertension (%) | 40 | 40 | 0.313 |
SBP (mmHg) | 142 ± 18 | 152 ± 23 | 0.005 |
DBP (mmHg) | 75 ± 12 | 78 ± 14 | 0.334 |
Data are means ± SD or median (interquartile range).
Those with KDM and on current treatment with tablets or insulin did not undergo an oral glucose tolerance test.
Newly diagnosed participants given duration of zero. DBP, diastolic blood pressure; SBP, systolic blood pressure.